• HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
ProAxsis Presenting New Data on NEATstik and New High Sensitivity Neutrophil Elastase Immunoassay at ATS 2018
Share
Conferences, NEATstik®, ProteaseTag®

ProAxsis Presenting New Data on NEATstik and New High Sensitivity Neutrophil Elastase Immunoassay at ATS 2018

May 2, 2018
-
Posted by David Ribeiro

ProAxsis confirms that new data on its ProteaseTag® technology will be presented at the American Thoracic Society Conference, which takes place between May 19th-24th in San Diego.

The University of Oxford team will be presenting data on NEATstik®, a novel point-of-care test for monitoring active neutrophil elastase in chronic diseases such as COPD, to the US respiratory community for the first time. NEATstik® gives a qualitative result from sputum in 10 minutes with minimal processing. The authors assessed 39 sputum samples and concluded that NEATstik® has the potential to identify those patients with elevated active NE concentrations which could be related to bacterial infection in patients with airways disease.

In addition, the company will be presenting data for the first time on the new, high sensitivity version of its immunoassay for measuring active neutrophil elastase. This immunoassay was developed in recognition of the fact that many researchers are seeking to measure biomarkers in respiratory fluids other than sputum, where the activity levels may be significantly lower. The assay development was co-funded by the UK’s innovation agency, Innovate UK.

Details of these two presentations can be found below:

EVALUATING THE SENSITIVITY AND SPECIFICITY OF NEATSTIK® TECHNOLOGY COMPARED TO AN ACTIVITY-BASED IMMUNOASSAY IN SPUTUM SAMPLES.

Presented by Professor Mona Bafhadhel, University of Oxford

 

AUGMENTATION OF PROTEASETAG® ACTIVE NEUTROPHIL ELASTASE IMMUNOASSAY SENSITIVITY

Presented by Dr Darragh McCafferty, ProAxsis Limited

 

Dr David Ribeiro, CEO of ProAxsis, said: “NEATstik® was registered with a European CE Mark in late 2017, and we’re delighted that the Oxford team will now be introducing initial data on the product to a US audience for the first time. We’re very grateful to Innovate UK for supporting the development of a new version of our Active Neutrophil Elastase Immunoassay, and look forward to making this product commercially available in the near future.”

 

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.

To find out how ProAxsis can support the measurement of active protease biomarkers of disease, or for any further queries, please contact info@proaxsis.com

May 2, 2018

Related News

Other posts that you should not miss.
Announcements, ProteaseTag®

ProAxsis technology highlighted in AJRCCM editorial

May 17, 2017
-
Posted by Webmaster

ProAxsis Ltd is delighted to observe that its ProteaseTag® Active Neutrophil Elastase Immunoassay is prominently featured in the …

Read More
May 17, 2017
Posted by Webmaster
News, ProteaseTag®

ProAxsis receives Royal visit

October 19, 2016
-
Posted by Webmaster

ProAxsis were this week delighted to host His Royal Highness, the Duke of York, at their new laboratory …

Read More
October 19, 2016
Posted by Webmaster
Conferences, News

ProAxsis CEO to present at Biotrinity 2016

April 19, 2016
-
Posted by Webmaster

Dr David Ribeiro, CEO of ProAxsis, will be attending the 10th anniversary Biotrinity conference, taking place in London on …

Read More
April 19, 2016
Posted by Webmaster
← PREVIOUS POST
ProAxsis receives further backing from Invest Northern Ireland under EU investment
NEXT POST →
New opportunity for Early Stage Researcher at Queen’s University Belfast
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis Limited appoints first distributor for DACH region
    December 14, 2020

    ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active …

  • ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19
    December 10, 2020

    ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been …

  • ProAxsis Limited recognised as Gold Level Innovator by Innovate NI
    December 2, 2020

    ProAxsis (www.proaxsis.com), the Belfast-based protease diagnostics company, is delighted to announce that it …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • February 21, 2021
    ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
  • December 14, 2020
    ProAxsis Limited appoints first distributor for DACH region
  • December 10, 2020
    ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19
LATEST TWEETS
Twitter
ProAxsis
Follow Me
ProAxsis is delighted to have received this support from Innovate UK - https://t.co/toTxOz9KK6
82 days ago
- ProAxsis
RT @GRobinsonDUP: I’m delighted that @ProAxsis based in East Belfast have been successful in their application for an Innovate UK Grant, wh…
82 days ago
- ProAxsis
We are delighted to announce that as of today, we have appointed an exclusive distributor for our portfolio of prod… https://t.co/rmCmIugsLa
103 days ago
- ProAxsis
Due to our continued expansion, we wish to recruit an Administration Officer. This post can be full-time or part-ti… https://t.co/k3wKwVfOKy
123 days ago
- ProAxsis
Copyright © 2016-2021 - ProAxsis - All rights reserved. 
ProAxsis Presenting New Data on NEATstik and New High Sensitivity Neutrophil Elastase Immunoassay at ATS 2018 | ProAxsis